Jie Li

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 33

Top Topics

Systematic Review

Coronavirus Disease

Hepatitis B Virus

Top Venues

Journal of viral hepatitis

Alimentary pharmacology & therapeutics

Journal of clinical and translational hepatology

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, Zhiwen Fan, Xiaoming Xu, Fajuan Rui, Wenjing Ni, Qi Gu, Xin Tong, Shengxia Yin, Xiaolong Qi, Junping Shi, Chao Wu, Jie Li
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes. Hepatology international 18 (3) (2024)
Fajuan Rui, Wenjing Ni, Yee Hui Yeo, Youwen Tan, Liang Xu, Jun-Ping Shi, Jie Li
The Reduced Accuracy of Non-invasive Tests for Significant Fibrosis in Chronic Hepatitis B Patients with Metabolic Dysfunction-associated Steatotic Liver Disease. Journal of clinical and translational hepatology 12 (9) (2024)
Xiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, Zhiwen Fan, Xiaoming Xu, Fajuan Rui, Wenjing Ni, Qi Gu, Xin Tong, Shengxia Yin, Xiaolong Qi, Junping Shi, Chao Wu, Jie Li
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes. Hepatology international (2024)
Xiaoming Xu, Fajuan Rui, Wenjing Ni, Chao Wu, Jun-Ping Shi, Jie Li
A Novel Algorithm for Streamlining Diagnosis of Advanced Liver Fibrosis in CHB Patients with Concurrent Hepatic Steatosis. Journal of clinical and translational hepatology 12 (2) (2024)
Xiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, Zhiwen Fan, Xiaoming Xu, Fajuan Rui, Wenjing Ni, Qi Gu, Xin Tong, Shengxia Yin, Xiaolong Qi, Junping Shi, Chao Wu, Jie Li
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes. Hepatology international 18 (3) (2024)
Wenjing Ni, Jun-Ping Shi, Jie Li
Epidemiology, natural history, and management of patients with CHB concurrent with MASLD. Clinical liver disease 23 (1) (2024)
Leijie Wang, Jian Wang, Kunyu Zhao, Lina Jiang, Xinxin Zhang, Jingming Zhao, Jie Li, Feng-Min Lu
The Relationship between Viral Replication and the Severity of Hepatic Necroinflammatory Damage Changed before HBeAg Loss in Patients with Chronic Hepatitis B Virus Infection. Journal of clinical and translational hepatology 12 (4) (2024)
Xiaolong Qi, Jie Li, Cyrielle Caussy, Gao-Jun Teng, Rohit S Loomba
Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. Hepatology (Baltimore, Md.) (2024)
Wenjing Ni, Jun-Ping Shi, Jie Li
Epidemiology, natural history, and management of patients with CHB concurrent with MASLD. Clinical liver disease 23 (1) (2024)
Leijie Wang, Jian Wang, Kunyu Zhao, Lina Jiang, Xinxin Zhang, Jingming Zhao, Jie Li, Feng-Min Lu
The Relationship between Viral Replication and the Severity of Hepatic Necroinflammatory Damage Changed before HBeAg Loss in Patients with Chronic Hepatitis B Virus Infection. Journal of clinical and translational hepatology 12 (4) (2024)
Jing Liu, Huiqing Zhang, Jianing Kong, Shiyi Liu, Liping Chen, Yanming Jiang, Jie Wang, Binbin Zhang, Xiaoping Ye, Ling Gong, Xiang Zhou, Gongying Chen, Jie Li, Xiao-Ben Pan, Haifeng Zhang, Junping Shi
Alleviated symptoms of SARS-CoV-2 Omicron variant infection in chronic hepatitis B patients with immune control. Journal of medical virology 95 (10) (2023)
Yixuan Zhu, Chuan Liu, Xiaoming Xu, Xiaoyan Ma, Jiacheng Liu, Zhiyi Zhang, Fuchao Li, Danny Ka-Ho Wong, Zhiwen Fan, Chao Wu, Xiaolong Qi, Jie Li
Association of Diabetes Mellitus with All-Cause and Cause-Specific Mortality among Patients with Metabolic-Dysfunction-Associated Fatty Liver Disease: A Longitudinal Cohort Study. Journal of personalized medicine 13 (3) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis (2023)
Yixuan Zhu, Chuan Liu, Xiaoming Xu, Xiaoyan Ma, Jiacheng Liu, Zhiyi Zhang, Fuchao Li, Danny Ka-Ho Wong, Zhiwen Fan, Chao Wu, Xiaolong Qi, Jie Li
Association of Diabetes Mellitus with All-Cause and Cause-Specific Mortality among Patients with Metabolic-Dysfunction-Associated Fatty Liver Disease: A Longitudinal Cohort Study. Journal of personalized medicine 13 (3) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis 30 (4) (2023)
Yingrui Wang, Qianru Zhu, Rui Sun, Xiao Yi, Lingling Huang, Yifan Hu, Weigang Ge, Huanhuan Gao, Xinfu Ye, Yu Song, Li Shao, Yantao Li, Jie Li, Tiannan Guo, Jun-Ping Shi
Longitudinal proteomic investigation of COVID-19 vaccination. Protein & cell (2023)
Xiaoming Xu, Jiacheng Liu, Chao Wu, Jie Li
Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary. Alimentary pharmacology & therapeutics 57 (10) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis 30 (4) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis 30 (4) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, He Zebao, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis (2023)
Xiaoming Xu, Jiacheng Liu, Chao Wu, Jie Li
Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary. Alimentary pharmacology & therapeutics 57 (10) (2023)
Xiaoming Xu, Jiacheng Liu, Chao Wu, Jie Li
Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary. Alimentary pharmacology & therapeutics 57 (10) (2023)
Run Zhou, Luping Yang, Binbin Zhang, Yunpeng Gu, Tingting Kong, Wei Zhang, Lei Sun, Chunlan Liu, Ningjia Kong, Jie Li, Jun-Ping Shi
Clinical impact of hepatic steatosis on chronic hepatitis B patients in Asia: A systematic review and meta-analysis. Journal of viral hepatitis (2023)
Yixuan Zhu, Chuan Liu, Xiaoming Xu, Xiaoyan Ma, Jiacheng Liu, Zhiyi Zhang, Fuchao Li, Danny Ka-Ho Wong, Zhiwen Fan, Chao Wu, Xiaolong Qi, Jie Li
Association of Diabetes Mellitus with All-Cause and Cause-Specific Mortality among Patients with Metabolic-Dysfunction-Associated Fatty Liver Disease: A Longitudinal Cohort Study. Journal of personalized medicine 13 (3) (2023)
Xiaoming Xu, Jiacheng Liu, Chao Wu, Jie Li
Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary. Alimentary pharmacology & therapeutics 57 (10) (2023)
Jie Li, Audrey Ha, Fajuan Rui, Biyao Zou, Hongli Yang, Qi Xue, Xinyu Hu, Yayun Xu, Linda Henry, Monique Barakat, Christopher D Stave, Junping Shi, Chao Wu, Ramsey Cheung, Mindie H Nguyen
Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021. Alimentary pharmacology & therapeutics 56 (3) (2022)
Tao Ma, Songning Ding, Rui Huang, Hengxue Wang, Junjun Wang, Jiacheng Liu, Jian Wang, Jie Li, Chao Wu, Huafeng Fan, Nan Zhou
The latent period of coronavirus disease 2019 with SARS-CoV-2 B.1.617.2 Delta variant of concern in the postvaccination era. Immunity, inflammation and disease 10 (7) (2022)
Chuanli Liu, Hongli Yang, Yuemin Feng, Cuihong Liu, Fajuan Rui, Yuankui Cao, Xinyu Hu, Jiawen Xu, Junqing Fan, Qiang Zhu, Jie Li
A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection. Journal of clinical and translational hepatology 10 (4) (2022)
Jie Li, Mindie H Nguyen
Letter to the editor: Screening for fatty liver disease and fibrosis in the elderly population: A call for action. Hepatology (Baltimore, Md.) (2022)
Jian Wang, Xiaomin Yan, Li Zhu, Jiacheng Liu, Yuanwang Qiu, Yiguang Li, Yilin Liu, Ruifei Xue, Jie Zhan, Suling Jiang, Yu Geng, Yawen Wan, Ming Li, Minxin Mao, Dongmei Gao, Shengxia Yin, Xin Tong, Juan Xia, Weimao Ding, Yuxin Chen, Jie Li, Chuanwu Zhu, Rui Huang, Chao Wu
Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone. Alimentary pharmacology & therapeutics (2022)
Jie Li, Mindie H Nguyen
Non-alcoholic fatty liver disease (NAFLD) in Asia-More efforts are needed. Liver international : official journal of the International Association for the Study of the Liver 40 (12) (2021)
Fajuan Rui, Hongli Yang, Zhaoyang Guo, Zhengming Ge, Xinyu Hu, Lulu Zhang, Qi Xue, Haiping Chen, Yayun Xu, Meng Tan, Chengyong Qin, Zebao He, Jie Li
Derivation and validation of prognostic models for predicting survival outcomes in Acute-on-chronic liver failure patients. Journal of viral hepatitis 28 (12) (2021)
Zebao He, Jie Li
Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398. Diabetes care 43 (10) (2020)